Log In
Print this Print this

Zinapar, darinaparsin (ZIO-101 oral)

  Manage Alerts
Collapse Summary General Information
Company Ziopharm Oncology Inc.
DescriptionOral mitochondrial and hedgehog-targeted organic arsenic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerSolasia Pharma K.K.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today